The target audience for this program is retina specialists.
Intravitreal Corticosteroids: Ensuring Effective Use with IOP Control Webinar 1
Media formats available:
Details
Presenters
Learning Objectives
Upon completion of this activity, the participant should be able to: - Identify risk factors associated with rises in IOP after steroid use
- Discuss management strategies for patients who experience rises in IOP after steroid use
- Assess clinical trial data pertaining to steroid implant therapies, including MEAD, FAME, BEVORDEX and OMAR
Accreditation
Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC, Retina Today and New Retina MD. Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Statement Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit. ™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Grantor Statement This continuing medical education activity is supported through an unrestricted educational grant from Allergan. Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve Medical Education LLC that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve Medical Education LLC has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following faculty members have the following financial relationships with commercial interests: Jason Bacharach, MD has had a financial agreement or affiliation during the past year with the following commercial interest(s) in the form of Consultant/Advisory Board/Speaker’s Bureau: Aerie Pharmaceuticals; Alcon, Allergan, Inc.; Glaukos Corporation; Lumenis; and Sucampo Pharmaceuticals, Inc. Stock Shareholder: Glaukos Corporation. Michael A. Singer, MD has had a financial agreement or affiliation during the past year with the following commercial interest(s) in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc. Grant/Research Support: Aerpio Therapeutics; Allergan, Inc.; Ampio Pharmaceuticals, Inc.; Genentech, Inc.; Ohr Pharmaceutical, Inc.; and Regeneron Pharmaceuticals, Inc. Charles Wykoff, MD has had a financial agreement or affiliation during the past year with the following commercial interest(s) in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon Laboratories, Inc.; Alimera Sciences, Inc.; Allergan, Inc.; Bayer; Clearside Biomedical, Inc.; DORC International; Genentech, Inc.; ONL Therapeutics; Regeneron Pharmaceuticals, Inc.; and ThromboGenics, Inc. Grant/Research Support: Acucela; Alcon Laboratories, Inc.; Allegro Optical Limited; Allergan, Inc.; Ampio Pharmaceuticals; Apellis Pharmaceutical; Bayer; Clearside Biomedical, Inc.; Genentech, Inc.; Iconic Therapeutics; pSivida; Opthotech Corportion; Regeneron Pharmaceuticals, Inc.; Santeen Pharmaceutical Co., Ltd; ThromboGenics, Inc.; and Xoma. Cheryl Cavanaugh, MS, Evolve Medical Education LLC; Emily Feinman, Retina Today and New Retina MD; and Michelle Dalton, Writer; have no real or apparent conflicts of interest to report. Rishi Singh, MD, Peer Reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Genentech, Inc; Regeneron Pharmaceuticals, Inc.; and ThromboGenics NV. Grant/Research Support: Alcon; Genentech, Inc; and Regeneron Pharmaceuticals, Inc.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!